Identifying molecular mechanisms that determine resistance to CDK4/6 inhibitors in HER2-enriched advanced luminal breast cancer 

Gregorio Jordán, Sara (Date of defense: 2021-12-03)

Breast Cancer (BCa) is the most prevalent cancer among women worldwide. It is a very heterogeneous disease at the histological, molecular and clinical level. Consequently, different classifications are used for stratifying ...